NO975962L - Legemiddelpreparat som omfatter albumin som aktiv bestanddel - Google Patents

Legemiddelpreparat som omfatter albumin som aktiv bestanddel

Info

Publication number
NO975962L
NO975962L NO975962A NO975962A NO975962L NO 975962 L NO975962 L NO 975962L NO 975962 A NO975962 A NO 975962A NO 975962 A NO975962 A NO 975962A NO 975962 L NO975962 L NO 975962L
Authority
NO
Norway
Prior art keywords
albumin
present
active ingredient
treatment
pharmaceutical composition
Prior art date
Application number
NO975962A
Other languages
English (en)
Other versions
NO975962D0 (no
NO320601B1 (no
Inventor
Kazuo Tsubota
Original Assignee
R Tech Ueno Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by R Tech Ueno Ltd filed Critical R Tech Ueno Ltd
Publication of NO975962D0 publication Critical patent/NO975962D0/no
Publication of NO975962L publication Critical patent/NO975962L/no
Publication of NO320601B1 publication Critical patent/NO320601B1/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/38—Albumins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/04—Artificial tears; Irrigation solutions

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
NO19975962A 1996-04-19 1997-12-18 Anvendelse av albumin til fremstilling av farmasoytiske preparater NO320601B1 (no)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
JP9809096 1996-04-19
JP10686696 1996-04-26
US75292896A 1996-11-21 1996-11-21
US75294196A 1996-11-21 1996-11-21
PCT/JP1997/001329 WO1997039769A1 (en) 1996-04-19 1997-04-17 Drug composition comprising albumin as active ingredient

Publications (3)

Publication Number Publication Date
NO975962D0 NO975962D0 (no) 1997-12-18
NO975962L true NO975962L (no) 1998-02-18
NO320601B1 NO320601B1 (no) 2005-12-27

Family

ID=27468604

Family Applications (1)

Application Number Title Priority Date Filing Date
NO19975962A NO320601B1 (no) 1996-04-19 1997-12-18 Anvendelse av albumin til fremstilling av farmasoytiske preparater

Country Status (11)

Country Link
US (2) US6043213A (no)
EP (1) EP0834320B1 (no)
JP (1) JP3058920B2 (no)
KR (1) KR100455475B1 (no)
CN (1) CN1124158C (no)
AT (1) ATE274918T1 (no)
CA (1) CA2225398C (no)
DE (1) DE69730476T2 (no)
ES (1) ES2227684T3 (no)
NO (1) NO320601B1 (no)
WO (1) WO1997039769A1 (no)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE60040856D1 (de) 1999-07-28 2009-01-02 Morinaga Milk Industry Co Ltd Lactalbumin zur kurativen Behandlung von Magengeschwüren
GB0019378D0 (en) * 2000-08-07 2000-09-27 Saugstad Ola D Method
ES2300398T3 (es) * 2001-04-26 2008-06-16 R-Tech Ueno, Ltd. Uso de albumina en combinacion con factores de crecimiento para inhibir la apoptosis.
US20030211043A1 (en) * 2001-09-28 2003-11-13 Korb Donald R. Eye treatment
US20060234907A1 (en) * 2004-02-13 2006-10-19 Werner Gehringer Albumin solution and process for the production thereof
US8455016B2 (en) 2004-03-12 2013-06-04 Melbj Holdings, Llc Treatment for meibomian gland dysfunction or obstruction
US20050202097A1 (en) * 2004-03-12 2005-09-15 Melbj Holdings, Llc, Florida Lubricant for the ocular surface
US7189697B2 (en) * 2004-04-13 2007-03-13 Trustees Of Tufts College Compositions and uses of a galectin for treatment of dry eye syndrome
US20060232060A1 (en) * 2005-04-13 2006-10-19 Assignee1 Pressure sensitive packing laminate overlay form combination and method of using same
WO2007033020A2 (en) * 2005-09-13 2007-03-22 Bausch & Lomb Incorporated Ophthalmic formulation for treatment of dry eye
WO2008133928A2 (en) * 2007-04-27 2008-11-06 The Gi Company, Inc. Mucin glycoproteins and their use for treatment of epithelial lesions and mucin dependent disorders
CA2724052A1 (en) * 2008-05-15 2009-11-19 R-Tech Ueno, Ltd. Pharmaceutical composition for the treatment of dry eye and/or corneal and conjunctival lesion
KR101422571B1 (ko) 2009-10-13 2014-07-24 삼성전자 주식회사 받침대 및 이를 구비한 세탁기
AU2013203609B2 (en) * 2009-11-27 2014-08-21 R-Tech Ueno, Ltd. Method for screening drug efficacious in treating dry eye and/or keratoconjunctival disorders and pharmaceutical composition obtained thereby
CA2780650A1 (en) * 2009-11-27 2011-06-03 R-Tech Ueno, Ltd. Method for screening an agent being useful for the treatment of dry eye and/or corneal and conjunctival lesion and a pharmaceutical composition obtained by the method
CN103501804A (zh) * 2010-12-21 2014-01-08 雷科制药公司 眼泪替代物
JP6629840B2 (ja) 2014-05-08 2020-01-15 パノプテス・ファーマ・ゲーエムベーハー 眼の疾患および障害を処置するための化合物
DE102015205293A1 (de) 2015-03-24 2016-09-29 Marc Schrott Verfahren zur Herstellung von Augentropfen
CN109195579B (zh) * 2016-04-01 2022-09-16 韩国比奥科斯全球公司 包含在细胞培养基中的白蛋白、透明质酸或胶原蛋白作为活性成分的化妆品组合物
AU2019232153B2 (en) * 2018-03-09 2023-07-13 Panoptes Pharma Ges.M.B.H. Ophthalmic formulation
US10966948B2 (en) 2019-07-23 2021-04-06 Johnson & Johnson Surgical Vision, Inc. Compositions and methods for treating the eye
BR112021000724A2 (pt) 2018-07-27 2021-04-13 Johnson & Johnson Surgical Vision, Inc. Composições e métodos para tratar os olhos
US20200030226A1 (en) 2018-07-27 2020-01-30 Johnson & Johnson Consumer Inc. Botanical and bacterial extracts displaying retinol-like activity
US11969454B2 (en) 2019-11-19 2024-04-30 Johnson & Johnson Surgical Vision, Inc. Compositions and methods for treating the eye
US12629445B2 (en) 2020-03-20 2026-05-19 Bard Peripheral Vascular, Inc. Reactive hydrogel forming formulations and related methods, including methods of preparation
US12161777B2 (en) 2020-07-02 2024-12-10 Davol Inc. Flowable hemostatic suspension
US11739166B2 (en) 2020-07-02 2023-08-29 Davol Inc. Reactive polysaccharide-based hemostatic agent
WO2022146917A1 (en) 2020-12-28 2022-07-07 Davol Inc. Reactive dry powdered hemostatic materials comprising a protein and a multifunctionalized modified polyethylene glycol based crosslinking agent
EP4558516B1 (en) 2022-07-18 2025-08-13 Yeda Research and Development Co. Ltd Albumin protein variants, production thereof and uses of same

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS57126422A (en) * 1981-01-29 1982-08-06 Green Cross Corp:The Stabilizing method of lysozyme pharmaceutical
JPS61103836A (ja) * 1984-10-24 1986-05-22 Green Cross Corp:The フイブロネクチン製剤
CA1263606A (en) * 1985-05-29 1989-12-05 Jeffrey P. Gilbard Non-toxic opthalmic preparations
JPS6391331A (ja) * 1986-10-03 1988-04-22 Senjiyu Seiyaku Kk 眼科用水性組成物
KR920700691A (ko) * 1989-04-04 1992-08-10 존.에프.맥인티리 상처부위, 절개부위, 찰과상 부위에 치료제의 투여에 대한 리포좀(liposomes)의 용도
US5174988A (en) * 1989-07-27 1992-12-29 Scientific Development & Research, Inc. Phospholipid delivery system
JPH05310592A (ja) * 1992-05-11 1993-11-22 Nichirei Corp 創傷治療剤及び医薬製剤
JPH06271478A (ja) * 1993-03-23 1994-09-27 Otsuka Pharmaceut Co Ltd ドライアイ治療剤
EP0637450A3 (en) * 1993-08-04 1995-04-05 Collagen Corp Method and composition for resuscitation of hereditary tissue.
US6013628A (en) * 1994-02-28 2000-01-11 Regents Of The University Of Minnesota Method for treating conditions of the eye using polypeptides

Also Published As

Publication number Publication date
DE69730476D1 (de) 2004-10-07
KR100455475B1 (ko) 2004-12-17
NO975962D0 (no) 1997-12-18
CA2225398C (en) 2008-07-15
EP0834320A4 (en) 2000-11-22
NO320601B1 (no) 2005-12-27
ES2227684T3 (es) 2005-04-01
US6043213A (en) 2000-03-28
EP0834320A1 (en) 1998-04-08
ATE274918T1 (de) 2004-09-15
CN1124158C (zh) 2003-10-15
US6159930A (en) 2000-12-12
WO1997039769A1 (en) 1997-10-30
KR19990028235A (ko) 1999-04-15
CN1195296A (zh) 1998-10-07
DE69730476T2 (de) 2005-11-17
CA2225398A1 (en) 1997-10-30
EP0834320B1 (en) 2004-09-01
JP3058920B2 (ja) 2000-07-04

Similar Documents

Publication Publication Date Title
NO975962D0 (no) Legemiddelpreparat som omfatter albumin som aktiv bestanddel
IL153665A0 (en) Topical pharmaceutical formulations and methods of treatment
PT88985A (pt) Processo para a preparacao de composicoes farmaceuticas nasais e ou oftalmicas contendo azelastina
ES2173287T3 (es) Composiciones oticas antibacterianas no irritantes, no sensibilizantes y no ototoxicas.
BR9708858A (pt) Formulaç o farmacêutica e processos para preparar a mesma e para tratar um disturbio em um paciente afetável por hormônio de crescimento
PT1040830E (pt) Medicamento para doencas neurodegenerativas
WO2002009702A3 (en) Use of indole derivatives for the manufacture of a medicament for reducing intracular pressure
EP1110554A4 (en) MEDICAL COMPOSITIONS FOR THE TREATMENT OF EYE DISEASES
DK0572190T3 (da) Oftalmiske præparater indeholdende vitamin E eller en ester deraf som en aktiv ingrediens
ATE179888T1 (de) Ophthalmische zubereitung zur behandlung oder prävention von trockenem auge und krankheiten, die dadurch verursacht werden, enthaltend 12- sulfodehydroabietsäure
PT1069902E (pt) Utilizacao de fosfolipidos na producao de um medicamento para a prevencao de adesoes
EP1074258A3 (en) Methods and compositions for treating diseases and conditions of the eye
BR0211970A (pt) Uso de bibn4096 em combinação com outras drogas antienxaqueca para o tratamento de enxaqueca
ATE337333T1 (de) Ophthalmische arzneimittelzusammenstellung
DK0979652T3 (da) Helbredende præparat til intraokulær hypertension eller glaukom
RU2008102249A (ru) Профилактический или терапевтичесский агент для корнеального /конъюнктивального заболевания
WO1995034302A3 (en) Method for reducing intraocular pressure in the mammalian eye by administration of calcium chelators
CA2429793A1 (en) Interferon therapeutic effect enhancer
ES2170807T3 (es) Uso de prostaglandinas para la fabricacion de un medicamento para la prevencion y el tratamiento de catarata secundaria.
AU643772B2 (en) Use of hexetidine or its derivatives or salts for the preparation of a pharmaceutical composition for ophthalmological use
AU4519189A (en) Medicaments for the treatment of toxoplasmosis
WO2001028578A3 (en) A PHARMACEUTICAL COMPOSITION CONTAINING pGLU-GLU-PRO-NH2 AND METHOD FOR TREATING DISEASES AND INJURIES TO THE BRAIN, SPINAL CORD AND RETINA USING SAME
JP5650864B2 (ja) 非イオン性シリコーンハイドロゲルコンタクトレンズ用眼科組成物
BR0114339A (pt) Composições farmaceuticamente aceitáveis contendo epinastina e pseudoefedrina
ES2073245T3 (es) Agentes para el tratamiento de la cornea.

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees